It's hard for some folks who suffer illness-related urinary incontinence to judge whether they'll be able to hold it until they get home, or if they should rush to a bathroom now. There might soon be ...

(Reuters Health) - Nearly half of women over age 50 report bladder leakage and many say it's a major problem for them, according to a new U.S. survey. Of the more than 1,000 women ages 50 to 80 who ...

After patients with non–muscle invasive bladder cancer fail to respond to treatment with BCG immunotherapy, Keytruda (pembrolizumab) may induce responses in these high-risk patients. After patients ...

U.S. drug regulators approved Astellas Pharma Inc's pill for overactive bladder on Thursday, boosting the Japanese drugmaker's foothold in the market for the condition. The Food and Drug ...

The FDA has approved mirabegron for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency. The drug, marketed by Astellas Pharma Inc.